Snowball logo
logo
BGLC

BioNexus Gene Lab Corp Common stock

BGLC β€’ NASDAQ
$1.55-$0.04Β  (2.52%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
13.3610.939.7708069.5106467.4249113.126581
COGS
11.179.6696788.4413088.2211256.3396942.762628
Gross Profit
2.193821.2590291.3294981.2895211.0852170.363953
Operating Expenses & Income
Operating Income
1.055827(0.291177)(2.593588)(1.573702)(3.15845)(2.588338)
Total Operating Expenses
1.1379931.5502063.9230862.8632234.2436673.420831
R&D Expenses
--0.0550.04750.05070.0541
Selling General & Admin Expenses
1.2044841.7294892.4428551.9739682.3302222.731587
Earnings from Continuing Operations
Interest Expense
(0.013)(0.0125)(0.0139)(0.0211)(0.0195)(0.0128)
Interest Income
--0.06870.1476410.08390.0477
Income Tax Expense
0.2912830.05230.02150.003494--
Net Income
Net Income
0.751571(0.355966)(2.629043)(1.598342)(2.984607)(2.575134)
Supplemental
EBIT
1.055827(0.291177)(2.593585)(1.573702)(2.965065)-
EBITDA
1.164042(0.185758)(2.485162)(1.420563)(2.796758)-
In millions of USD, except % and values per 1 share